This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 14 Oct 2014  |  North America

    Industry Financial Review of the Global Laboratory Research Tools Market

    Cautious Optimism for Continued Recovery

    This study provides an analysis of the global laboratory research tools market, segmented by the United States (US), Canada, Europe, Japan, India, China, Brazil, Mexico, and Rest of World (ROW). Product categories analyzed include instruments and equipment, consumables, and chemicals, reagents and kits. The US market is also segmented by end users,...

    $1,500.00
  2. 13 Oct 2014  |  North America

    Analysis of the US Immunochemistry Market

    Clinicians Will Likely Opt for Integrated Analyzers over Standalone Clinical and Immunoassay Analyzers in the Next 2 Years

    This study provides trends in the US immunochemistry market and the clinical chemistry market. The install base of analyzer models from top vendors are projected from 2012 and 2013, and resulting trends have been studied. The study includes list prices of analyzers, analytes detected, and average discounts offered. Customer segmentation includes va...

    $3,950.00
  3. As with every cardiology tradeshow today, the show floor of the 2014 European Society of Cardiology (ESC) Congress in Barcelona (Aug. 30-Sept. 3) reserved quite a significant presence for medical imaging. This comes as no surprise, since imaging and informatics continues to reaffirm their role as an important driving force for advancing several are...

    $450.00
  4. 08 Oct 2014  |  North America

    European and US Hantavirus Diagnostics

    European Market Shows more Promise than the US Owing to Higher Prevalence Rates

    Hantavirus is a disease that is prevalent in Europe and has shown to have almost fifty percent mortality rate in the US. The increased mortality rate is due to inaccesibility to diagnostic tests and the mis-diagnosis of the disease. This report offers revenue forecasts for the Hantavirus diagnostic market for each of the following regions European,...

    $1,500.00
  5. 07 Oct 2014  |  Global

    Analysis of the Global Stem Cell Market

    The key to Transforming Future of Diagnostic and Therapeutic Medicine

    This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...

    $3,950.00
  6. This issue of Vital Signs, released on October 3, 2014, discusses Merck KGaAs acquisition of Sigma-Aldrich, highlights from the 2014 AACC Meeting, Abbotts CE Mark for FreeStyle® Libre, laboratory developed test (LDT) regulations, and the sale of Fortis Healthcares Singapore subsidiary, RadLink-Asia Pte Ltd, and its arm, RadLink Singapore.

    $450.00
  7. Electronic cigarettes and vaping products have taken the tobacco industry by storm. Multiple public reports have e-cigarettes surpassing traditional tobacco sales within the next six to ten years if growth rates continue to climb. Due to the lack of Food and Drug Administration (FDA) regulation, e-cigarette year-over-year growth declined from 2010-...

    $450.00
  8. 29 Sep 2014  |  Europe

    Western European Liquid Handling Market

    Increasing Demand for High Throughput Data Drives Adoption of Automated Liquid Handling Instruments

    The increasing life science research activities across drug discovery applications have driven the need for automated products in liquid handling. How far the automated segments are going to replace the manual instruments is analyzed in this research. This study provides the market overview, market engineering measurements, revenue forecasts, compa...

    $3,950.00
  9. The wearables market is currently a center of hype and interest across the varied landscape of consumers, vendors, providers, payers, and other stakeholders interested in the broader digital health market. Companies are trying to better understand consumer habits, exploring device monetization outside of the early adopting fitness crowd, increasing...

    $450.00
  10. 23 Sep 2014  |  North America

    Analysis of the Global Infectious Disease Diagnostics Market

    Molecular Methods Present Significant Opportunities

    This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

    $3,950.00